MiR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-α in human breast cancer cells

R. Spizzo, M. S. Nicoloso, L. Lupini, Y. Lu, J. Fogarty, S. Rossi, B. Zagatti, M. Fabbri, A. Veronese, X. Liu, R. Davuluri, C. M. Croce, G. Mills, M. Negrini, G. A. Calin

    Research output: Contribution to journalArticle

    183 Scopus citations

    Abstract

    Understanding the consequences of miR-145 reintroduction in human breast cancer (BC) could reveal its tumor-suppressive functions and may disclose new aspects of BC biology. Therefore, we characterized the effects of miR-145 re-expression in BC cell lines by using proliferation and apoptosis assays. As a result, we found that miR-145 exhibited a pro-apoptotic effect, which is dependent on TP53 activation, and that TP53 activation can, in turn, stimulate miR-145 expression, thus establishing a death-promoting loop between miR-145 and TP53. We also found that miR-145 can downregulate estrogen receptor-α (ER-α) protein expression through direct interaction with two complementary sites within its coding sequence. In conclusion, we described a tumor suppression function of miR-145 in BC cell lines, and we linked miR-145 to TP53 and ER-α. Moreover, our findings support a view that miR-145 re-expression therapy could be mainly envisioned in the specific group of patients with ER-α-positive and/or TP53 wild-type tumors.

    Original languageEnglish (US)
    Pages (from-to)246-254
    Number of pages9
    JournalCell Death and Differentiation
    Volume17
    Issue number2
    DOIs
    StatePublished - Feb 1 2010

      Fingerprint

    Keywords

    • Apoptosis
    • Cell proliferation
    • ER-a
    • Human BC
    • MiR-145
    • TP53

    ASJC Scopus subject areas

    • Molecular Biology
    • Cell Biology

    Cite this

    Spizzo, R., Nicoloso, M. S., Lupini, L., Lu, Y., Fogarty, J., Rossi, S., Zagatti, B., Fabbri, M., Veronese, A., Liu, X., Davuluri, R., Croce, C. M., Mills, G., Negrini, M., & Calin, G. A. (2010). MiR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-α in human breast cancer cells. Cell Death and Differentiation, 17(2), 246-254. https://doi.org/10.1038/cdd.2009.117